In fact, women with IUGR associate to e-PE are identifiable from the significant increase of EGFL7 maternal levels, while isolated IUGR, without maternal systemic involvement and diffuse endothelial damage, are characterized by low detectable maternal circulating levels of EGFL7 along all gestation. The gene discussed is EGFL7; the disease is fetal growth restriction.